The evaluation for safety and efficacy of combination therapy of adoptive immune-cell therapy with chemoradiotherapy for locally advanced esophageal cancer
- Conditions
- ocally advanced esophageal cancer
- Registration Number
- JPRN-UMIN000017350
- Lead Sponsor
- Gunma University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Not provided
(1) Patient with interstitial pneumonia (2) Patient who received cancer immunotherapy (3) Patient with active autoimmune disease (4) Patient with active heart disease (5) Patient with uncontrollable infectious diseases (6) Patient with serious drug allergy (7) Patient with uncontrollable diabetes mellitus (8) Patient with active multiple malignancies (9) Patient with continuous use of systemic administration of steroids (10) Patient with severe psychological disorders (11) Patient in pregnancy (12) Patient positive for HIV or HTLV-1 (13) Current participation in other drug clinical trials. (excluding the study, which doesn't need intervention) (14) Patients who are inadequate to enter this study due to the other reasons by physician's judgments
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method